From a screen targeting 35 genes implicated in lipid metabolism and/or NAFLD risk, FADS2 (fatty acid desaturase 2) emerged as an important determinant of hepatic steatosis. Here, FADS2 is linked to metabolic dysfunction-associated steatotic liver disease.